Formulating for the Future of Transplant Patient Therapy

Transplant Support

Veloxis is a specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs.

Veloxis is an international company with headquarters in Hørsholm, Denmark, and a fully owned subsidiary in Edison, New Jersey, USA.

Veloxis is committed to patient access and financial support for kidney transplant patients. Learn more about our prescription cost savings programs, click here Go to


May 19, 2016
Conference Call Announcing Interim Report for the first Quarter 2016

Webcast Webcast
PDF Q1 2016 Presentation
 363.5 KB   Add to Briefcase

Conference call at 3:00 pm CEST

Please dial in 5-10 minutes prior to the start time using the number / Conference ID below.

UK: +44(0)20 3427 1910

US: +1 646 254 3362

DK: +45 32 71 16 59

Confirmation Code:  8446996

Stock Information